The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from any sale by the selling securityholders of the shares of common stock offered by this prospectus.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
- Bionano Genomics announces publication of first multi-site study on OGM
- Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- BioNano Genomics Launches $10M Share & Warrant Offering
- Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules